A patent is personal property. It can be sold, mortgaged, bequeathed, and split among owners, and the transaction that transfers it outright is an assignment. Inventors sitting on a granted patent they never commercialized ask a reasonable question: can I just sell this and be done? The answer is yes, and the follow-up stings, because most patents sell for far less than their owners spent obtaining them.

Understanding why that is, and what separates the assets that fetch real money from the ones nobody wants, is most of what you need before you start contacting buyers.

Selling Versus Licensing: Pick Deliberately

An assignment transfers all rights permanently for a payment. You are out. There is no ongoing revenue, no continuing obligation, and no further risk. This suits an inventor who has moved on, an estate settling assets, or a company shedding technology outside its focus.

A license keeps ownership with you and grants defined rights in exchange for royalties, an upfront payment, or both. The upside is larger if the product succeeds, and so is the administrative burden: you have to audit, enforce, and maintain the patent for its full life. The structures involved are laid out in how patent licensing works, and typical economics in invention royalty rates.

There are hybrids. Assign the patent but retain a license back for your own field of use. Sell with a share of any future enforcement recovery. Sell for a fixed sum plus milestone payments if the buyer commercializes. All of these are ordinary and negotiable.

Who Actually Buys Patents

  • Operating companies in your field. The best buyers. They purchase to launch a product line, to remove a blocking position, or to strengthen a portfolio for cross-licensing. They pay for relevance to their roadmap.
  • Competitors of a known infringer. If a large company is practicing your claims, its rivals sometimes have strategic reasons to own the right to stop them.
  • Patent aggregators and licensing entities. Firms that buy portfolios to license or assert. They pay less per asset, move faster, and are entirely transactional. Defensive aggregators buy to neutralize risk for their members.
  • Investors and funds. Litigation finance and IP funds occasionally acquire assets with clear evidence of use and large damages exposure.
  • Universities and research institutions. Rarely buyers, sometimes partners.

Approaching operating companies is a business development exercise, not a legal one, and the targeting method is the same as described in which companies buy invention ideas: find the product manager whose line your patent touches, not the general counsel.

What Buyers Actually Pay For

Buyers are not paying for cleverness. They are paying for a specific, checkable set of attributes.

Claim scope that reads on real products. The single largest value driver is an evidence-of-use analysis: a claim chart mapping each element of an independent claim onto a product currently being sold. A patent with a credible chart against a shipping product is a different asset class from one without, even if the underlying idea is identical.

Granted, not pending. Applications sell, at a discount, because the claims are not yet fixed.

Remaining term. A patent with four years left is worth a fraction of the same patent with twelve.

Clean chain of title. Every inventor must have assigned their rights to you in a recorded document. A missing signature from a former contractor or co-inventor can stop a sale dead.

Family breadth. Continuations still pending, foreign counterparts in major markets, and a design patent alongside the utility patent all raise the price, because the buyer gains the ability to pursue further claims.

Paid maintenance fees. An expired or lapsed patent has no value at all, which is why the schedule in patent maintenance fees matters right up to the closing date.

Setting an Asking Price

There is no public price index, and comparables are scarce because most transactions are confidential. Practical anchors are the cost approach, meaning what it would cost the buyer to file and prosecute equivalent coverage from scratch, and the income approach, meaning the royalty stream the patent could plausibly support discounted for risk. The methodologies are compared in how to value a patent.

Be realistic about the distribution. A large share of individually offered patents never sell at any price, and those that do often close in the tens of thousands of dollars. Six- and seven-figure outcomes cluster almost entirely among patents with documented use by a solvent company in a large market. Anchoring to headline numbers from telecommunications portfolios will keep you from doing a reasonable deal.

Broker Red Flags

Legitimate IP brokers work on a success fee, usually a percentage of the sale, and will tell you honestly when your asset is not marketable. That conversation is unpleasant and valuable.

Be skeptical of anyone who asks for thousands of dollars up front for a valuation report, a market study, or inclusion in a database of inventions. Firms that charge for submitting your invention to companies are required by federal law to disclose their success statistics, and those disclosures are worth reading precisely because the numbers are usually dismal. The pattern is documented in invention help companies and how to avoid scams.

Other warning signs: guaranteed outcomes, refusal to name a single past transaction, pressure to sign a long exclusive representation period, and a proposal to buy your patent themselves for a nominal sum plus a promised royalty.

Closing the Transaction

The sale runs on a patent purchase agreement covering price and payment structure, representations about ownership and validity, disclosure of prior licenses and encumbrances, allocation of any past infringement claims, and which party carries maintenance fees going forward. Buyers will conduct diligence on the file history, and anything you said during prosecution can narrow the claims through estoppel.

The transfer itself is a short assignment document, recorded with the USPTO's assignment recordation system. Recording puts the world on notice, and an unrecorded assignment can be defeated by a later purchaser. The mechanics and traps are detailed in how patent ownership actually transfers. Handle the tax treatment with an accountant before signing, since structure affects whether proceeds are capital gain or ordinary income.

Raising the Value Before You Sell

The reliable way to increase what a patent fetches is to reduce the buyer's uncertainty: a working product that demonstrates the claims are practicable, manufacturing data showing it can be built at cost, and evidence that a market exists. Projects House builds exactly that package around an existing patent. Tell us what you hold and what you want to do with it through our contact form.